---

SeungSuh (Stanley) Hong

President and Chief Executive Officer, Celltrion Healthcare Co. Ltd

Stanley is both a scientist and a business man. He joined Celltrion in 2002 and is said to have made many contributions to the successful development of the company; he was also involved in the development of Remsima, the first biosimilar monoclonal antibody to be approved by the European Medicines Agency.

---

Part of the Power List 2016

The Top 100

The nominations are in and after considerable debate and analysis from our judging panel, we present The Power List 2016 – our second foray into the Top 100 most influential people in the world of drug development and manufacture.

Go to The Power List 2016